BIOCQBiocept, Inc.

About Biocept, Inc. (BIOCQ)

Biocept, Inc. (BIOCQ) is a Diagnostics & Research company headquartered in San Diego, CA, United States whose shares trade over-the-counter on the Expert Market tier.

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients.

BIOCQ key facts

Ticker symbol

BIOCQ

Market tier

Expert Market

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

San Diego, CA, United States

Country of incorporation

US

Estimated market cap

$262.603 (as of Apr 11, 2025)

Shares outstanding

2,626,026

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Explore more: Diagnostics & Research stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with B